Japan, Aug. 6 -- AMGEN has got intellectual property rights for 'VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE-3 (TIMP-3), COMPOSITIONS AND METHODS.' Other related details are as follows:
Application Number: JP,2025-163035
Category (FI): A61P19/10,A61P19/08,A61P17/02,A61P27/02,A61P1/02,A61P17/00,A61P29/00,101,A61P9/00,A61P17/06,A61P1/04,A61P11/00,A61P11/06,A61P29/00,A61P19/02,A61P9/10,A61P9/04,A61K38/57,C12P21/02@C,C12N5/10,C12N1/21,C12N1/19,C12N1/15,C12N15/63@Z,C12N15/15,C07K14/81,A61P1/00,A61P1/18,A61P3/10,A61P1/16,A61P25/00,A61P31/12,A61P31/20,A61P31/14,A61P37/06,A61P21/00,A61P25/02,A61P9/10,101,A61P21/04,A61P37/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Sept. 30, 2025
Publication Date: Ja...